ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,427Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 198

$498K Total Retail Price of All Prescriptions

Rank: 60 out of 198

332 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,599 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 458 242 S3 1 8
LEVOTHYROXINE SODIUM 263 224 2 1
FUROSEMIDE 243 210 3 5
OMEPRAZOLE 207 127 4 3
METOPROLOL TARTRATE 200 176 5 10
ZOLPIDEM TARTRATE 178 136 6 22
PRAVASTATIN SODIUM 177 111 7 19
POTASSIUM CHLORIDE 163 153 8 9
CLINDAMYCIN PHOSPHATE 163 0 8 207
CIPROFLOXACIN HCL 147 106 10 55
SIMVASTATIN 123 106 11 2
AMLODIPINE BESYLATE 115 100 12 4
MELOXICAM 111 77 13 30
METFORMIN HCL 108 106 14 13
KENALOG-40 107 0 10 15 230
LISINOPRIL 105 76 16 6
WARFARIN SODIUM 102 84 17 7
CELEBREX 102 88 17 59
GABAPENTIN 100 60 19 14
NEXIUM 96 75 20 40
GLIMEPIRIDE 95 91 21 35
OXYCODONE HCL 91 44 S2 22 112
TAMSULOSIN HCL 87 83 23 27
HYDROCHLOROTHIAZIDE 85 65 24 16
ATORVASTATIN CALCIUM 85 67 24 12
TRAMADOL HCL 84 59 26 15
METHYLPHENIDATE HCL 83 72 27 242
LOSARTAN-HYDROCHLOROTHIAZIDE 81 79 28 49
ALENDRONATE SODIUM 78 57 29 21
PROPRANOLOL HCL 78 61 29 92
CARISOPRODOL 77 13 R 31 198
METOCLOPRAMIDE HCL 77 51 31 136
OXYCODONE-ACETAMINOPHEN 75 54 S2 33 79
AMLODIPINE BESYLATE-BENAZEPRIL 73 72 34 99
CITALOPRAM HBR 70 56 35 20
METOPROLOL SUCCINATE 70 55 35 11
FLUTICASONE PROPIONATE 68 57 37 39
CRESTOR 67 54 38 26
ALLOPURINOL 67 35 38 23
TRICOR 65 41 40 93
ENDOCET 65 19 S2 40 218
HYDRALAZINE HCL 64 44 42 111
CEPHALEXIN 63 35 43 108
ATENOLOL 63 41 43 17
SYNTHROID 63 56 43 36
PREDNISONE 62 42 46 29
AMITRIPTYLINE HCL 59 39 R 47 69
BENAZEPRIL HCL 58 58 48 45
MIRTAZAPINE 57 31 49 44
FAMOTIDINE 57 46 49 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 43 51 90
CYCLOBENZAPRINE HCL 53 24 R 52 67
CLONIDINE HCL 53 26 52 52
FENOFIBRATE 50 25 54 61
IBUPROFEN 50 19 54 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.